These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 18180653)

  • 1. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
    Chiam PT; Ruiz CE
    J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter occlusion of the left atrial appendage for stroke prevention.
    Bayard YL; Ostermayer SH; Sievert H
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1003-8. PubMed ID: 16292991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Left Atrial Appendage Exclusion Therapy: Who, Why and How?
    Möbius-Winkler S; Dähnert I; Schuler GC; Sick PB
    J Atr Fibrillation; 2009; 2(3):178. PubMed ID: 28496638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interventional prevention of ischemic stroke].
    Kamtchueng P; Teiger E
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):411-8. PubMed ID: 24200350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
    Waksman R; Pendyala LK
    Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation.
    Price MJ
    Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
    Block PC; Burstein S; Casale PN; Kramer PH; Teirstein P; Williams DO; Reisman M
    JACC Cardiovasc Interv; 2009 Jul; 2(7):594-600. PubMed ID: 19628179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes.
    Park JW; Leithäuser B; Gerk U; Vrsansky M; Jung F
    J Invasive Cardiol; 2009 Sep; 21(9):446-50. PubMed ID: 19726815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive surgical implantation of the percutaneous left atrial appendage transcatheter occlusion device: initial experience in a canine model.
    Hill AC; Guy TS
    Innovations (Phila); 2012; 7(1):52-8. PubMed ID: 22576036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpharmacologic stroke prevention in atrial fibrillation.
    Onalan O; Lashevsky I; Hamad A; Crystal E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs.
    Lobodzinski SS
    Cardiol J; 2009; 16(4):375-8. PubMed ID: 19653186
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
    Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
    Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.